Guenzle, J.; Akasaka, H.; Joechle, K.; Reichardt, W.; Venkatasamy, A.; Hoeppner, J.; Hellerbrand, C.; Fichtner-Feigl, S.; Lang, S.A.
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. Int. J. Mol. Sci. 2021, 22, 30.
https://doi.org/10.3390/ijms22010030
AMA Style
Guenzle J, Akasaka H, Joechle K, Reichardt W, Venkatasamy A, Hoeppner J, Hellerbrand C, Fichtner-Feigl S, Lang SA.
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. International Journal of Molecular Sciences. 2021; 22(1):30.
https://doi.org/10.3390/ijms22010030
Chicago/Turabian Style
Guenzle, Jessica, Harue Akasaka, Katharina Joechle, Wilfried Reichardt, Aina Venkatasamy, Jens Hoeppner, Claus Hellerbrand, Stefan Fichtner-Feigl, and Sven A. Lang.
2021. "Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma" International Journal of Molecular Sciences 22, no. 1: 30.
https://doi.org/10.3390/ijms22010030
APA Style
Guenzle, J., Akasaka, H., Joechle, K., Reichardt, W., Venkatasamy, A., Hoeppner, J., Hellerbrand, C., Fichtner-Feigl, S., & Lang, S. A.
(2021). Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. International Journal of Molecular Sciences, 22(1), 30.
https://doi.org/10.3390/ijms22010030